DUBLIN--(BUSINESS WIRE)--The "Global Fractional Flow Reserve Devices Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The analysts forecast the global fractional flow reserve devices market to grow at a CAGR of 13.54% during the period 2018-2022.
FFR devices are used for the measurement of FFR, a technique used to determine the effect of narrowing or stenosis in coronary arteries on blood flow.
The report covers the present scenario and the growth prospects of the global fractional flow reserve devices market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
One trend in the market is increasing number of product approvals. Until 2014, the global fractional flow reserve devices market consisted of only two major companies, namely Abbott and Koninklijke Philips.
One driver in the market is increasing prevalence of CADs. The prevalence of CADs such as stable angina, unstable angina, MI, and sudden cardiac deaths is increasing worldwide. CVDs are expected to cause approximately 19 million deaths worldwide by 2020.
The report states that one challenge in the market is low adoption of FFR. Despite all the clinical and economic evidence and revascularization guidelines recommending the use of FFR, the technique is still in its early stages of adoption in several developing countries.
- Boston Scientific
- Koninklijke Philips
Key Topics Covered:
1: Executive Summary
2: Scope Of The Report
3: Research Methodology
4: Market Landscape
5: Market Sizing
6: Five Forces Analysis
7: Market Segmentation By Product
8: Market Segmentation By Application
9: Customer Landscape
10: Regional Landscape
11: Decision Framework
12: Drivers And Challenges
13: Market Trends
14: Vendor Landscape
15: Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/3m75wf/global_fractional?w=4